Literature DB >> 9576551

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.

K M Myhr1, T Riise, E Barrett-Connor, H Myrmel, C Vedeler, M Grønning, M B Kalvenes, H Nyland.   

Abstract

OBJECTIVE: The prevalence of anti-EBV antibodies was studied in a group of 144 patients with multiple sclerosis and 170 age, sex, and area matched controls from the county of Hordaland, western Norway. The prevalence of three other herpesviruses, herpes simplex virus (HSV), varicella zoster virus (VZV), and cytomegalovirus (CMV), were also included.
METHODS: Antibodies to various virus antigens were determined by enzyme linked immunosorbent assay (ELISA) and indirect immunfluorescence (IIF) in serum samples from 144 patients with multiple sclerosis and 170 controls.
RESULTS: All of the 144 patients with multiple sclerosis had IgG antibodies to EBV compared with 162 of 170 controls (p=0.008). The frequency of IgG antibodies to EBV capsid antigen (VCA), nuclear antigen (EBNA), and early antigen (EA) was significantly higher in patients with multiple sclerosis compared with the controls (p<0.000001, p=0.01, and p<0.0001 respectively). The presence of antibodies was independent of the initial course of the disease and the disease activity at the time of blood sampling. The prevalence of IgG antibodies to HSV, CMV, and VZV did not differ between cases and controls.
CONCLUSION: The results suggest a role for EBV in the aetiology of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576551      PMCID: PMC2170022          DOI: 10.1136/jnnp.64.4.539

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis.

Authors:  Gloudina M Hon; Mogamat S Hassan; Susan J van Rensburg; Rajiv T Erasmus; Tandi E Matsha
Journal:  Metab Brain Dis       Date:  2012-03-10       Impact factor: 3.584

2.  Multiple sclerosis and Epstein-Barr virus.

Authors:  Ruth Ann Marrie; Christina Wolfson
Journal:  Can J Infect Dis       Date:  2002-03

3.  Cytomegalovirus and multiple sclerosis risk.

Authors:  Julia Pakpoor; Jina Pakpoor; Giulio Disanto; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

4.  Epstein-Barr virus and disease activity in multiple sclerosis.

Authors:  D Buljevac; G J J van Doornum; H Z Flach; J Groen; A D M E Osterhaus; W Hop; P A van Doorn; F G A van der Meché; R Q Hintzen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

5.  EBV seroepidemiology in married and unmarried women and men in Iran.

Authors:  Morteza Pourahamad; Farhang Hooshmand; Sara Olyaee Nezhad; Abdolali Sepidkar
Journal:  Rep Biochem Mol Biol       Date:  2014-04

6.  Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production.

Authors:  O Santiago; J Gutierrez; A Sorlozano; J de Dios Luna; E Villegas; O Fernandez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-29       Impact factor: 3.267

7.  Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis.

Authors:  J W Lindsey; L M Hatfield; T Vu
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

8.  Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis.

Authors:  Daniela Pohl; Kevin Rostasy; Christian Jacobi; Peter Lange; Roland Nau; Bernd Krone; Folker Hanefeld
Journal:  J Neurol       Date:  2009-08-28       Impact factor: 4.849

9.  Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.

Authors:  Ellen M Mowry; Emmanuelle Waubant; Charles E McCulloch; Darin T Okuda; Alan A Evangelista; Robin R Lincoln; Pierre-Antoine Gourraud; Don Brenneman; Mary C Owen; Pamela Qualley; Monica Bucci; Stephen L Hauser; Daniel Pelletier
Journal:  Ann Neurol       Date:  2012-08       Impact factor: 10.422

10.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.